Table 3.
Target Lesion Device Use.a
| Baseline RC |
p |
|||||
|---|---|---|---|---|---|---|
| RC2,3 (n=605)b | RC4,5 (n=775)b | RC6 (n=148)b | RC2,3 vs RC4,5 | RC2,3 vs RC6 | RC4,5 vs RC6 | |
| Balloons | ||||||
| Angioplasty | 494/597 (82.7) | 635/766 (82.9) | 96/142 (67.6) | 0.94 | <0.001 | <0.001 |
| DCB | 74/597 (12.4) | 54/766 (7.0) | 11/142 (7.7) | 0.001 | 0.14 | 0.72 |
| Cutting | 42/597 (7.0) | 58/766 (7.6) | 26/142 (18.3) | 0.75 | <0.001 | <0.001 |
| Focal Force | 73/597 (12.2) | 97/766 (12.7) | 31/142 (21.8) | 0.87 | 0.005 | 0.006 |
| Scoring | 3/597 (0.5) | 7/766 (0.9) | 4/142 (2.8) | 0.53 | 0.03 | 0.08 |
| Atherectomy devices | ||||||
| Diamondback, Stealth | 274/437 (45.9) | 347/494 (45.3) | 88/107 (62.0) | 0.83 | 0.001 | <0.001 |
| Jetstream | 19/437 (3.2) | 12/494 (1.6) | 1/107 (0.7) | 0.07 | 0.15 | 0.70 |
| Excimer laser | 35/437 (5.9) | 39/494 (5.1) | 15/107 (10.6) | 0.55 | 0.06 | 0.02 |
| Rotablator | 7/437 (1.2) | 7/494 (0.9) | 0/107 (0.0) | 0.79 | 0.36 | 0.60 |
| Turbohawk, Silverhawk, Hawk One | 87/437 (14.6) | 82/494 (10.7) | 5/107 (3.5) | 0.04 | <0.001 | 0.005 |
| Phoenix | 6/437 (1.0) | 14/494 (1.8) | 0/107 (0.0) | 0.26 | 0.60 | 0.14 |
| Crosser | 14/437 (2.3) | 8/494 (1.0) | 0/107 (0.0) | 0.08 | 0.08 | 0.62 |
| Stents | ||||||
| DES | 34/120 (5.7) | 37/111 (4.8) | 12/25 (8.5) | 0.54 | 0.25 | 0.10 |
| BMS | 88/120 (14.7) | 72/111 (9.4) | 16/25 (11.3) | 0.003 | 0.35 | 0.54 |
| Covered | 5/120 (0.8) | 6/111 (0.8) | 0/25 (0.0) | >0.99 | 0.59 | 0.60 |
Abbreviations: BMS, bare metal stent; DCB, drug-coated balloon; DES, drug-eluting stent; RC, Rutherford category.
a
Categorical data are given as the number (percentage).
b
Number of lesions unless otherwise noted.